Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1

Saved in:
Bibliographic Details
Published in:Blood 2024-11, Vol.144 (Supplement 1), p.883-883
Main Authors: Danilov, Alexey, Fakhri, Bita, Awan, Farrukh T., Bentzen, Hans Herluf, Eradat, Herbert A., Niemann, Carsten Utoft, Offner, Fritz, Poulsen, Christian Bjørn, Hoeyer, Thor, Bellido, Mar, Roos Weil, Damien, Ferrajoli, Alessandra, Thompson, Meghan C., Christensen, Jacob Haaber, Janssens, Ann, Tadmor, Tamar, Shadman, Mazyar, Jafarinasabian, Pegah, Zhang, Jimin, Rios, Marcia, Kuznetsova, Alexandra, Valentin, Rebecca, Kater, Arnon P.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 883
container_issue Supplement 1
container_start_page 883
container_title Blood
container_volume 144
creator Danilov, Alexey
Fakhri, Bita
Awan, Farrukh T.
Bentzen, Hans Herluf
Eradat, Herbert A.
Niemann, Carsten Utoft
Offner, Fritz
Poulsen, Christian Bjørn
Hoeyer, Thor
Bellido, Mar
Roos Weil, Damien
Ferrajoli, Alessandra
Thompson, Meghan C.
Christensen, Jacob Haaber
Janssens, Ann
Tadmor, Tamar
Shadman, Mazyar
Jafarinasabian, Pegah
Zhang, Jimin
Rios, Marcia
Kuznetsova, Alexandra
Valentin, Rebecca
Kater, Arnon P.
description
doi_str_mv 10.1182/blood-2024-199708
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2024_199708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1182_blood_2024_199708</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1182_blood_2024_1997083</originalsourceid><addsrcrecordid>eNqdkM1OhDAUhRujifjzAO7uEhY4LcM44JZgZoFxQtyTDpRQhd6m7UTxtXxBy-gTuLonJ_fce_IRcsfoPWNZsjqMiF2c0CSNWZ5vaXZGArZJspjShJ6TgFL6EKf5ll2SK2vfKGXpOtkE5LvULRrp-MQP8IwK3SAM1zNIBXvupFDOQrh3NoIP6Qaoxci1FR2g8bo3vHVoZgjrVR1BMRhUsoVqnvSA7ewWLY7vYpIcwqKqokcfssfR3-wNTuAtKD81V1aiAq46eNFOTvLLf_ZGgQMav4s9nGqKJRCzG3LR89GK2795TdhT-Vrs4tagtUb0jTZy4mZuGG0WOs2JTrPQaX7prP-T-QHfKnCT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1</title><source>ScienceDirect</source><creator>Danilov, Alexey ; Fakhri, Bita ; Awan, Farrukh T. ; Bentzen, Hans Herluf ; Eradat, Herbert A. ; Niemann, Carsten Utoft ; Offner, Fritz ; Poulsen, Christian Bjørn ; Hoeyer, Thor ; Bellido, Mar ; Roos Weil, Damien ; Ferrajoli, Alessandra ; Thompson, Meghan C. ; Christensen, Jacob Haaber ; Janssens, Ann ; Tadmor, Tamar ; Shadman, Mazyar ; Jafarinasabian, Pegah ; Zhang, Jimin ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Kater, Arnon P.</creator><creatorcontrib>Danilov, Alexey ; Fakhri, Bita ; Awan, Farrukh T. ; Bentzen, Hans Herluf ; Eradat, Herbert A. ; Niemann, Carsten Utoft ; Offner, Fritz ; Poulsen, Christian Bjørn ; Hoeyer, Thor ; Bellido, Mar ; Roos Weil, Damien ; Ferrajoli, Alessandra ; Thompson, Meghan C. ; Christensen, Jacob Haaber ; Janssens, Ann ; Tadmor, Tamar ; Shadman, Mazyar ; Jafarinasabian, Pegah ; Zhang, Jimin ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Kater, Arnon P.</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2024-199708</identifier><language>eng</language><ispartof>Blood, 2024-11, Vol.144 (Supplement 1), p.883-883</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Danilov, Alexey</creatorcontrib><creatorcontrib>Fakhri, Bita</creatorcontrib><creatorcontrib>Awan, Farrukh T.</creatorcontrib><creatorcontrib>Bentzen, Hans Herluf</creatorcontrib><creatorcontrib>Eradat, Herbert A.</creatorcontrib><creatorcontrib>Niemann, Carsten Utoft</creatorcontrib><creatorcontrib>Offner, Fritz</creatorcontrib><creatorcontrib>Poulsen, Christian Bjørn</creatorcontrib><creatorcontrib>Hoeyer, Thor</creatorcontrib><creatorcontrib>Bellido, Mar</creatorcontrib><creatorcontrib>Roos Weil, Damien</creatorcontrib><creatorcontrib>Ferrajoli, Alessandra</creatorcontrib><creatorcontrib>Thompson, Meghan C.</creatorcontrib><creatorcontrib>Christensen, Jacob Haaber</creatorcontrib><creatorcontrib>Janssens, Ann</creatorcontrib><creatorcontrib>Tadmor, Tamar</creatorcontrib><creatorcontrib>Shadman, Mazyar</creatorcontrib><creatorcontrib>Jafarinasabian, Pegah</creatorcontrib><creatorcontrib>Zhang, Jimin</creatorcontrib><creatorcontrib>Rios, Marcia</creatorcontrib><creatorcontrib>Kuznetsova, Alexandra</creatorcontrib><creatorcontrib>Valentin, Rebecca</creatorcontrib><creatorcontrib>Kater, Arnon P.</creatorcontrib><title>Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqdkM1OhDAUhRujifjzAO7uEhY4LcM44JZgZoFxQtyTDpRQhd6m7UTxtXxBy-gTuLonJ_fce_IRcsfoPWNZsjqMiF2c0CSNWZ5vaXZGArZJspjShJ6TgFL6EKf5ll2SK2vfKGXpOtkE5LvULRrp-MQP8IwK3SAM1zNIBXvupFDOQrh3NoIP6Qaoxci1FR2g8bo3vHVoZgjrVR1BMRhUsoVqnvSA7ewWLY7vYpIcwqKqokcfssfR3-wNTuAtKD81V1aiAq46eNFOTvLLf_ZGgQMav4s9nGqKJRCzG3LR89GK2795TdhT-Vrs4tagtUb0jTZy4mZuGG0WOs2JTrPQaX7prP-T-QHfKnCT</recordid><startdate>20241105</startdate><enddate>20241105</enddate><creator>Danilov, Alexey</creator><creator>Fakhri, Bita</creator><creator>Awan, Farrukh T.</creator><creator>Bentzen, Hans Herluf</creator><creator>Eradat, Herbert A.</creator><creator>Niemann, Carsten Utoft</creator><creator>Offner, Fritz</creator><creator>Poulsen, Christian Bjørn</creator><creator>Hoeyer, Thor</creator><creator>Bellido, Mar</creator><creator>Roos Weil, Damien</creator><creator>Ferrajoli, Alessandra</creator><creator>Thompson, Meghan C.</creator><creator>Christensen, Jacob Haaber</creator><creator>Janssens, Ann</creator><creator>Tadmor, Tamar</creator><creator>Shadman, Mazyar</creator><creator>Jafarinasabian, Pegah</creator><creator>Zhang, Jimin</creator><creator>Rios, Marcia</creator><creator>Kuznetsova, Alexandra</creator><creator>Valentin, Rebecca</creator><creator>Kater, Arnon P.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20241105</creationdate><title>Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1</title><author>Danilov, Alexey ; Fakhri, Bita ; Awan, Farrukh T. ; Bentzen, Hans Herluf ; Eradat, Herbert A. ; Niemann, Carsten Utoft ; Offner, Fritz ; Poulsen, Christian Bjørn ; Hoeyer, Thor ; Bellido, Mar ; Roos Weil, Damien ; Ferrajoli, Alessandra ; Thompson, Meghan C. ; Christensen, Jacob Haaber ; Janssens, Ann ; Tadmor, Tamar ; Shadman, Mazyar ; Jafarinasabian, Pegah ; Zhang, Jimin ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Kater, Arnon P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1182_blood_2024_1997083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Danilov, Alexey</creatorcontrib><creatorcontrib>Fakhri, Bita</creatorcontrib><creatorcontrib>Awan, Farrukh T.</creatorcontrib><creatorcontrib>Bentzen, Hans Herluf</creatorcontrib><creatorcontrib>Eradat, Herbert A.</creatorcontrib><creatorcontrib>Niemann, Carsten Utoft</creatorcontrib><creatorcontrib>Offner, Fritz</creatorcontrib><creatorcontrib>Poulsen, Christian Bjørn</creatorcontrib><creatorcontrib>Hoeyer, Thor</creatorcontrib><creatorcontrib>Bellido, Mar</creatorcontrib><creatorcontrib>Roos Weil, Damien</creatorcontrib><creatorcontrib>Ferrajoli, Alessandra</creatorcontrib><creatorcontrib>Thompson, Meghan C.</creatorcontrib><creatorcontrib>Christensen, Jacob Haaber</creatorcontrib><creatorcontrib>Janssens, Ann</creatorcontrib><creatorcontrib>Tadmor, Tamar</creatorcontrib><creatorcontrib>Shadman, Mazyar</creatorcontrib><creatorcontrib>Jafarinasabian, Pegah</creatorcontrib><creatorcontrib>Zhang, Jimin</creatorcontrib><creatorcontrib>Rios, Marcia</creatorcontrib><creatorcontrib>Kuznetsova, Alexandra</creatorcontrib><creatorcontrib>Valentin, Rebecca</creatorcontrib><creatorcontrib>Kater, Arnon P.</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Danilov, Alexey</au><au>Fakhri, Bita</au><au>Awan, Farrukh T.</au><au>Bentzen, Hans Herluf</au><au>Eradat, Herbert A.</au><au>Niemann, Carsten Utoft</au><au>Offner, Fritz</au><au>Poulsen, Christian Bjørn</au><au>Hoeyer, Thor</au><au>Bellido, Mar</au><au>Roos Weil, Damien</au><au>Ferrajoli, Alessandra</au><au>Thompson, Meghan C.</au><au>Christensen, Jacob Haaber</au><au>Janssens, Ann</au><au>Tadmor, Tamar</au><au>Shadman, Mazyar</au><au>Jafarinasabian, Pegah</au><au>Zhang, Jimin</au><au>Rios, Marcia</au><au>Kuznetsova, Alexandra</au><au>Valentin, Rebecca</au><au>Kater, Arnon P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1</atitle><jtitle>Blood</jtitle><date>2024-11-05</date><risdate>2024</risdate><volume>144</volume><issue>Supplement 1</issue><spage>883</spage><epage>883</epage><pages>883-883</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><doi>10.1182/blood-2024-199708</doi></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2024-11, Vol.144 (Supplement 1), p.883-883
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2024_199708
source ScienceDirect
title Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T14%3A02%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epcoritamab%20Monotherapy%20in%20Patients%20(Pts)%20with%20Relapsed%20or%20Refractory%20(R/R)%20Chronic%20Lymphocytic%20Leukemia%20(CLL):%20Results%20from%20CLL%20Expansion%20and%20Optimization%20Cohorts%20of%20Epcore%20CLL-1&rft.jtitle=Blood&rft.au=Danilov,%20Alexey&rft.date=2024-11-05&rft.volume=144&rft.issue=Supplement%201&rft.spage=883&rft.epage=883&rft.pages=883-883&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2024-199708&rft_dat=%3Ccrossref%3E10_1182_blood_2024_199708%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1182_blood_2024_1997083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true